Clinical Trial Update: Immune Response to Cytomegalovirus

View source ↗

Summary

The document reports the completion/update of an NHLBI-sponsored clinical trial studying immune responses to cytomegalovirus infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infections

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cytomegalovirus Infections | Status: COMPLETED